EFFECT OF BETA-ADRENERGIC - BLOCKADE ON AORTIC ROOT RATE OF DILATION IN THE MARFAN-SYNDROME

被引：108

作者：

SALIM, MA ^{[1
]}

ALPERT, BS ^{[1
]}

WARD, JC ^{[1
]}

PYERITZ, RE ^{[1
]}

机构：

[1] JOHNS HOPKINS MED INST,CTR MED GENET,DEPT MED,BALTIMORE,MD

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1994年 / 74卷 / 06期

关键词：

D O I：

10.1016/0002-9149(94)90762-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We recommend that patients with the Marfan syndrome should begin P-adrenergic blocker therapy at the earliest age possible and that the dose be adjusted to the largest dose that is clinically tolerated. Our centers differ with respect to the size of the aorta at the time of recommending onset of therapy. The JHH criteria do not include a size cutoff. The UT experience and recommendation is to treat children with aortic size at or above the 95th percentile. © 1994.

引用

页码：629 / 633

页数：5

共 14 条

[1] INTERNATIONAL NOSOLOGY OF HERITABLE DISORDERS OF CONNECTIVE-TISSUE, BERLIN, 1986 [J].

BEIGHTON, P ;

DEPAEPE, A ;

DANKS, D ;

FINIDORI, G ;

GEDDEDAHL, T ;

GOODMAN, R ;

HALL, JG ;

HOLLISTER, DW ;

HORTON, W ;

MCKUSICK, VA ;

OPITZ, JM ;

POPE, FM ;

PYERITZ, RE ;

RIMOIN, DL ;

SILLENCE, D ;

SPRANGER, JW ;

THOMPSON, E ;

TSIPOURAS, P ;

VILJOEN, D ;

WINSHIP, I ;

YOUNG, I .

AMERICAN JOURNAL OF MEDICAL GENETICS, 1988, 29 (03) :581-594

[2] THE HEART OF THE MATTER - CARDIOVASCULAR INVOLVEMENT IN MARFANS-SYNDROME [J].

CHILD, JS ;

PERLOFF, JK ;

KAPLAN, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (02) :429-431

[3] THE SKIPPING OF CONSTITUTIVE EXONS INVIVO INDUCED BY NONSENSE MUTATIONS [J].

DIETZ, HC ;

VALLE, D ;

FRANCOMANO, CA ;

KENDZIOR, RJ ;

PYERITZ, RE ;

CUTTING, GR .

SCIENCE, 1993, 259 (5095) :680-683

[4] MARFAN PHENOTYPE VARIABILITY IN A FAMILY SEGREGATING A MISSENSE MUTATION IN THE EPIDERMAL GROWTH-FACTOR LIKE MOTIF OF THE FIBRILLIN GENE [J].

DIETZ, HC ;

PYERITZ, RE ;

PUFFENBERGER, EG ;

KENDZIOR, RJ ;

CORSON, GM ;

MASLEN, CL ;

SAKAI, LY ;

FRANCOMANO, CA ;

CUTTING, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1674-1680

[5] ECHOCARDIOGRAPHIC MEASUREMENTS IN NORMAL SUBJECTS FROM INFANCY TO OLD-AGE [J].

HENRY, WL ;

GARDIN, JM ;

WARE, JH .

CIRCULATION, 1980, 62 (05) :1054-1061

[6] MARFANS-SYNDROME - NATURAL-HISTORY AND LONG-TERM FOLLOW-UP OF CARDIOVASCULAR INVOLVEMENT [J].

MARSALESE, DL ;

MOODIE, DS ;

VACANTE, M ;

LYTLE, BW ;

GILL, CC ;

STERBA, R ;

COSGROVE, DM ;

PASSALACQUA, M ;

GOORMASTIC, M ;

KOVACS, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (02) :422-428

[7] MARFAN-SYNDROME - DEFECTIVE SYNTHESIS, SECRETION, AND EXTRACELLULAR-MATRIX FORMATION OF FIBRILLIN BY CULTURED DERMAL FIBROBLASTS [J].

MILEWICZ, DM ;

PYERITZ, RE ;

CRAWFORD, ES ;

BYERS, PH .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :79-86

[8]

MORSE RP, 1990, PEDIATRICS, V86, P888

[9] LIFE EXPECTANCY AND CAUSES OF DEATH IN MARFAN SYNDROME [J].

MURDOCH, JL ;

KUZMA, JW ;

HALPERN, BL ;

WALKER, BA ;

MCKUSICK, VA .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (15) :804-+

[10]

PYERITZ RE, 1983, CIRCULATION, V68, P365

← 1 2 →